Lv3
270 积分 2022-10-25 加入
Application of Model‐Informed Drug Development in Dose Selection and Optimization for siRNA Therapies
22小时前
待确认
Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study
1天前
已完结
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
3天前
已完结
Tirzepatide vs Insulin Lispro Added to Basal Insulin in Type 2 Diabetes
3天前
已完结
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
22天前
已完结
The effect of intravenous ondansetron on QT interval in the emergency department
24天前
已完结
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
26天前
已完结
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
26天前
已完结
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
27天前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
27天前
已完结
皖公网安备34019202002308
